Related Experiment Video

Updated: Apr 29, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

140.3K

Rituximab and B-cell return in ANCA-associated vasculitis

Benjamin Wilde1, Oliver Witzke2, Jan Willem Cohen Tervaert3

  • 1University Hospital Maastricht, Maastricht, the Netherlands; University Duisburg-Essen, University Hospital Essen, Essen, Germany.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|May 27, 2014
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

4.2K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.0K

Related Experiment Videos

Last Updated: Apr 29, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

140.3K
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

4.2K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.0K

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

876
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
876
Autoimmune Disorders01:29

Autoimmune Disorders

2.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K

Articles linked to this work by shared authors, journal, and citation graph.

Biosimilar Rituximab in ANCA-Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study.

ACR open rheumatology·2026

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Frontiers in immunology·2026

Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significance.

Clinical kidney journal·2026

Follow-Up 18F-Fluorodeoxyglucose Positron Emission Tomography in Treated Patients With Giant Cell Arteritis: A Systematic Review and Metaanalysis.

The Journal of rheumatology·2026

Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert survey.

Rheumatology (Oxford, England)·2026

Long-term persistence of pneumococcal antibodies 5 years after a sequential PCV13 and PPSV23 vaccination in kidney transplant recipients: indications for revaccination.

mSphere·2026

Advances in Understanding of Long-Term Living Kidney Donor Risks.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

12-year Follow-up of a Family With CKD Caused by an mtDNA Variant.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Blood Pressure, Kidney Function, and Kidney Mortality Among Mexican Adults.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Artificial Intelligence-Enabled Electrocardiography for Monitoring Serum Potassium Dynamics in Patients With Severe Hypokalemia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Evidence for the Use of Steroidal Aldosterone Antagonists in Patients With Kidney Failure.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Spectrum of Anti-Factor B-Associated Glomerular Diseases in Adults.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Nanoparticle-enabled CD40 silencing programs immune tolerance via a DC-Treg-Breg axis in autoimmune myocarditis.

Materials today. Bio·2026

Infliximab-Associated IgA Vasculitis Masquerading as Crohn's Disease Relapse: Leukocytoclastic Vasculitis Confirmed on Duodenal Biopsy - A Case Report.

Inflammatory intestinal diseases·2026

Ethosuximide-induced lupus erythematosus: Unveiling a rare adverse reaction through systematic review.

Epilepsy & behavior reports·2026

Case Report: Elderly anti-GBM antibody disease with diffuse non-hereditary glomerular basement membrane thinning of uncertain etiology.

Frontiers in medicine·2026

Autoimmune thyroiditis in pregnancy: epidemiology, clinical impact, and contemporary management challenges.

Journal of medicine and life·2026

TREM2 as a central immunometabolic hub in Alzheimer's disease: linking microglial states, lipid stress, and disease-stage-specific intervention.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us